Urine metabolite profiling offers potential early diagnosis of oral cancer

Metabolomics

Volumn 8, Issue 2, 2012, Pages 220-231

  Xie, Guo X ^a,b   Chen, Tian L ^c   Qiu, Yun P ^b   Shi, Peng ^d   Zheng, Xiao J ^a   Su, Ming M ^a   Zhao, Ai H ^a   Zhou, Zeng T ^d   Jia, Wei ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c Shanghai Jiao Tong University   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gas chromatography mass spectrometry; Metabolomics; Metabonomics; Multivariate statistical analysis; Oral cancer; Oral leukoplakia; Oral squamous cell carcinoma; Receiver operating characteristic; Urine

Indexed keywords

3 METHYLGLUTAKONIC ACID; 6 HYDROXYNICOTINIC ACID; ALANINE; CYSTEINE; CYSTINE; GLUTAMINE; HIPPURIC ACID; HISTAMINE; HISTIDINE; LEUCINE; NICOTINIC ACID; PALMITIC ACID; PHENYLALANINE; SERINE; TRYPTOPHAN; TUMOR MARKER; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; HUMAN; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; URINALYSIS;

EID: 84857789813     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0302-7     Document Type: Article

References (37)

1. Banjac, A., Perisic, T., Sato, H., et al. (2008). The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death. Oncogene, 27(11), 1618-1628.
2. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate-a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B-Methodological, 57(1), 289-300.
3. Chan, E. C. Y., Koh, P. K., Mal, M., et al. (2009). Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). Journal of Proteome Research, 8(1), 352-361.
4. Chung, W. J., Lyons, S. A., Nelson, G. M., et al. (2005). Inhibition of cystine uptake disrupts the growth of primary brain tumors. Journal of Neuroscience, 25(31), 7101-7110.
5. Claus, S. P., Tsang, T. M., Wang, Y. L., et al. (2008). Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Molecular Systems Biology, 4, 219.
6. Dunn, W. B., Bailey, N. J., & Johnson, H. E. (2005). Measuring the metabolome: Current analytical technologies. Analyst, 130(5), 606-625.
7. Epstein, J. B., Zhang, L., & Rosin, M. (2002). Advances in the diagnosis of oral premalignant and malignant lesions. Journal of the Canadian Dental Association, 68, 617-621.
8. 2 lymphoma cells. Leukemia, 11(8), 1329-1337.
9. Griffin, J. L., & Shockcor, J. P. (2004). Metabolic profiles of cancer cells. Nature Reviews Cancer, 4(7), 551-561.
10. Hirayama, A., Kami, K., Sugimoto, M., et al. (2009). Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Research, 69(11), 4918-4925.
11. Ishigure, K., Shimomura, Y., Murakami, T., et al. (2001). Human liver disease decreases methacrylyl-CoA hydratase and beta-hydroxyisobutyryl-CoA hydrolase activities in valine catabolism. Clinica Chimica Acta, 312(1-2), 115-121.
12. Kantola, S. P. M., Jokinen, K., Hyrynkangs, K., Soini, Y., Alho, O. P., & Salo, T. (2000). Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors. British Journal of Cancer, 83, 614-619.
13. Kind, T., Tolstikov, V., Fiehn, O., & Weiss, R. H. (2007). A comprehensive urinary metabolomic approach for identifying kidney cancer. Analytical Biochemistry, 363(2), 185-195.
14. Li, Y., St John, M. A. R., Zhou, X. F., et al. (2004). Salivary transcriptome diagnostics for oral cancer detection. Clinical Cancer Research, 10(24), 8442-8450.
15. Mao, L., Hong, W. K., & Papadimitrakopoulou, V. A. (2004). Focus on head and neck cancer. Cancer Cell, 5, 311-316.
16. Myers, J. N., Elkins, T., Roberts, D., & Byers, R. M. (2000). Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngology: Head and Neck Surgery, 122, 44-51.
17. Ni, Y., Su, M. M., Lin, J. C., et al. (2008). Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress. FEBS Letters, 582(17), 2627-2636.
18. Ni, Y., Su, M., Qiu, Y., et al. (2007). Metabolic profiling using combined GC-MS and LC-MS provides a systems understanding of aristolochic acid-induced nephrotoxicity in rat. FEBS Letters, 581(4), 707-711.
19. Pelayo, B. A., Fu, Y. M., & Meadows, G. G. (2001). Decreased tissue plasminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine. International Journal of Oncology, 18(4), 877-883.
20. Qin, G. S., & Hotilovac, L. (2008). Comparison of non-parametric confidence intervals for the area under the ROC curve of a continuous-scale diagnostic test. Statistical Methods in Medical Research, 17(2), 207-221.
21. Qiu, Y., Cai, G., Su, M., et al. (2009). Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. Journal of Proteome Research, 8, 4844-4850.
22. Qiu, Y. P., Cai, G. X., Su, M. M., et al. (2010). Urinary metabonomic study on colorectal cancer. Journal of Proteome Research, 9(3), 1627-1634.
23. Qiu, Y. P., Su, M. M., Liu, Y. M., et al. (2007). Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling. Analytica Chimica Acta, 583, 277-283.
24. Scully, C., & Felix, D. H. (2006). Oral medicine-update for the dental practitioner-oral cancer. British Dental Journal, 200(1), 13-17.
25. Spustova, V., & Oravec, C. (1989). Antitumor effect of hippurate-an experimental-study using various mouse-tumor strains. Neoplasma, 36(3), 317-320.
26. Storey, J. D. (2002). A direct approach to false discovery rates. Journal of the Royal Statistical Society Series B-Statistical Methodology, 64, 479-498.
27. Sugimoto, M., Wong, D. T., Hirayama, A., Soga, T., & Tomita, M. (2010). Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics, 6(1), 78-95.
28. Tiziani, S., Lopes, V., & Gunther, U. L. (2009). Early stage diagnosis of oral cancer using H-1 NMR-based metabolomics. Neoplasia, 11(3), 269-276.
29. Wei, J., Xie, G. X., Zhou, Z. T., et al. (2010). Salivary metabolite signatures of oral cancer and leukoplakia. International Journal of Cancer. doi: 10. 1002/ijc. 25881.
30. Wong, D. T. (2006). Towards a simple, saliva-based test for the detection of oral cancer. Expert Review of Molecular Diagnostics, 6, 267-272.
31. Wu, H., Xue, R. Y., Dong, L., et al. (2009a). Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Analytica Chimica Acta, 648(1), 98-104.
32. Wu, H., Xue, R. Y., Lu, C. L., et al. (2009b). Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 877(27), 3111-3117.
33. Wu, H., Xue, R. Y., Tang, Z. Q., et al. (2010). Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry. Analytical and Bioanalytical Chemistry, 396(4), 1385-1395.
34. Xu, G. Q., Li, B. Q., & Li, H. H. (1992). Oral precancerous pathological changes-oral leukoplakia and oral lichen planus. Beijing: Chinese Medical Science and Technology Publishing House.
35. Yan, S. K., Wei, B. J., Lin, Z. Y., Yang, Y., Zhou, Z. T., & Zhang, W. D. (2008). A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia. Oral Oncology, 44(5), 477-483.
36. Ye, Z. C., & Sontheimer, H. (1999). Glioma cells release excitotoxic concentrations of glutamate. Cancer Research, 59(17), 4383-4391.
37. Zhou, J. L., Xu, B., Huang, J., et al. (2009). H-1 NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma. Clinica Chimica Acta, 401(1-2), 8-13.